Stay updated on Moderna Press Releases
Sign up to get notified when there's something new on the Moderna Press Releases page.

Latest updates to the Moderna Press Releases page
- Check7 days agoChange DetectedNew press releases were added to the News and Blog Posts list: 'Moderna Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Provides Business Updates' (February 13, 2026) and 'Moderna Receives European Commission Marketing Authorization for COVID-19 Vaccine mNEXSPIKE' (February 17, 2026). The stock data values in the header were updated.SummaryDifference1%

- Check14 days agoChange DetectedStock price and volume were updated from $42.20 / 9.36M to $41.99 / 9.99M. Two new press releases were added: 'Moderna to Enter into Long-Term Strategic Agreement with the Government of Mexico' and 'Moderna Receives Refusal-to-File Letter from the FDA for Its Investigational Seasonal Influenza Vaccine, mRNA-1010'.SummaryDifference2%

- Check21 days agoChange DetectedTwo new press releases were added to the News and Blog Posts list, including Dr. David Berman joining Moderna as Chief Development Officer and a strategic collaboration with Recordati. The top stock quote updated from $45.45 (15.24M) to $42.20 (9.36M).SummaryDifference2%

- Check28 days agoChange DetectedAdded new press releases such as 'Registration-Ready: How 2026's Clinical Leaders Are Beating Cancer Benchmarks' and 'Moderna to Report Fourth Quarter 2025 Financial Results on Friday, February 13, 2026,' and updated stock data ($45.83, 10.82M); older announcements were removed.SummaryDifference6%

- Check35 days agoChange DetectedAdds multiple new press release entries with dates and headlines, expanding core News content; removes the loading placeholder.SummaryDifference8%

- Check50 days agoChange DetectedAdded 2026 to the year selector and removed 2025 from the year options, updating the available archive year options.SummaryDifference0.3%

Stay in the know with updates to Moderna Press Releases
Enter your email address, and we'll notify you when there's something new on the Moderna Press Releases page.